0
2022
Transjugular Intrahepatic Portosystemic Shunt (tips) Market

Transjugular Intrahepatic Portosystemic Shunt (TIPS) Market

by Device Type (Stents, Accessories), by Application (Portal hypertension, Budd Chiari Syndrome, Others), by End User (Hospitals, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Report Code: A31429
Pages: 206
Oct 2022 | 500 Views
Author(s) : Shraddha M , Onkar S
Tables: 144
Charts: 58
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Transjugular Intrahepatic Portosystemic Shunt (TIPS) Market Research, 2031

The global transjugular intrahepatic portosystemic shunt (TIPS) market size was valued at $93.4 million in 2021, and is projected to reach $127.9 million by 2031, growing at a CAGR of 3.2% from 2022 to 2031.

Transjugular intrahepatic portosystemic shunt (TIPS) is a major advancement in the treatment of portal hypertension. It is also used for the treatment of hepatorenal syndrome, and Budd-chirai syndrome. TIPS is a hemodynamic equivalent of a side to side small diameter surgical shunt. The shunt itself is created by placing a stent between portal vein and hepatic vein. TIPS stent is placed via interventional radiology which uses aseptic technique. In this procedure a needle catheter is passed via the right internal jugular vein to the hepatic vein, and then a tract is made to the intrahepatic portion of the portal vein.Transjugular intrahepatic portosystemic shunt is a major advancement in the treatment of portal hypertension. It is also used for the treatment of hepatorenal syndrome, and Budd-chirai syndrome. TIPS is a hemodynamic equivalent of a side to side small diameter surgical shunt. The shunt itself is created by placing a stent between portal vein and hepatic vein. TIPS stent is placed via interventional radiology which uses aseptic technique. In this procedure a needle catheter is passed via the right internal jugular vein to the hepatic vein, and then a tract is made to the intrahepatic portion of the portal vein.

The COVID-19 outbreak had a negative impact on the growth of the global transjugular intrahepatic portosystemic shunt (TIPS) market. Government of many countries imposed lockdown restrictions which resulted in cancellation or postponement of elective surgical procedures; subsequently resulting in lower adoption of surgical devices for TIPS surgery.

Transjugular Intrahepatic Portosystemic Shunt (TIPS) Market

Growth of the global TIPS market is majorly driven by rise in prevalence of liver disease such as portal hypertension, hepatorenal syndrome, Budd-Chirai Syndrome and others, increase in risk of organ failure, and development of new transjugular intrahepatic portosystemic shunt (TIPS) devices by large number of key players. Furthermore, according to the World Obesity Federation, it is estimated that approximately 2.7 billion adults will be overweight, over 1 billion affected by obesity, and 177 thousand adults severely affected by obesity by 2025. Being overweight or obese causes fat to accumulate in the liver. This leads to scarring of the liver also known as cirrhosis. Thus, surge in obesity population leads to large population with liver disease and increase demand for transjugular intrahepatic portosystemic shunt (TIPS) devices, which is anticipated to foster the growth of the market. Furthermore, growing incidence of portal vein thrombosis and other liver diseases among geriatric population, increase in demand for TIPS surgery due to shortage of organ donors are some of the major factors that fuel the transjugular intrahepatic portosystemic shunt (TIPS) market growth.

Also, according to the National Institute on Alcohol Abuse and Alcoholism in 2019, alcohol facts and statistics, it was estimated that approximately 85,688 liver disease deaths among individuals with ages 12 and older. Among males, 53,486 liver disease deaths occurred, and 45.6% involved alcohol. Among females, 32,202 liver disease deaths occurred, and 39.0% involved alcohol. Thus, such high mortality can be avoided by appropriate liver treatment at the right time, and thus is expected to boosts the growth of the TIPS market. Furthermore, increase in number of product approvals is expected to provide remunerative opportunities for the expansion of the global transjugular intrahepatic portosystemic shunt (TIPS) market during the forecast period.

The transjugular intrahepatic portosystemic shunt (tips) market size is classified into End User, Device Type and Application. On the basis of device type, it is divided into stents and accessories. By application, the market is classified into portal hypertension, Budd-chirai Syndrome, and others. By end user, the market is bifurcated into hospitals, specialty clinics, and others.

Region-wise, the transjugular intrahepatic portosystemic shunt (TIPS) market share is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Segment Review

Depending on device type, the stents segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to increase in R&D activities in the medical device industry, and rise in demand for TIPS devices. However, the accessories segment is expected to witness considerable growth during the forecast period, owing to increase in number of minimally invasive surgeries and rise in number of key players for development of accessories for TIPS in the medical device industry.

Transjugular Intrahepatic Portosystemic Shunt (TIPS) Market

By application, the portal hypertension segment was the major contributor in 2021, and is expected to maintain its lead during the forecast period, owing to increase in number of cases of portal hypertension, and increase in demand for transjugular intrahepatic portosystemic shunt (TIPS) in patient who suffer from liver disease. However, the others segment is expected to witness considerable growth during the forecast period, due to increase in number of case of hepatorenal syndrome, and cirrhosis.

Transjugular Intrahepatic Portosystemic Shunt (TIPS) Market

By end user, the hospitals segment was the major contributor in 2021, and is expected to maintain its lead during the forecast period, owing to increase in number of hospital admission, and increase in demand for TIPS devices. However, the specialty clinics segment is expected to witness considerable growth during the forecast period due to increase in demand for special treatment, and presence of well-trained medical staff in specialty clinics.

Transjugular Intrahepatic Portosystemic Shunt (TIPS) Market

North America garnered the major transjugular intrahepatic portosystemic shunt (TIPS) market share in 2021, and is expected to continue to dominate during the forecast period, owing to rise in number of liver surgeries, presence of key players, development of the healthcare sector, and presence of new innovative TIPS devices in the region. However, Asia-Pacific is expected to register the highest CAGR during transjugular intrahepatic portosystemic shunt (TIPS) market Forecast, owing to increase in use for lifetime support and development of healthcare infrastructure.

Transjugular Intrahepatic Portosystemic Shunt (TIPS) Market

The key players that operate in the transjugular intrahepatic portosystemic shunt industry include, Boston Scientific Corporation, Becton Dickinson and Company, Angiodynamics Inc, Cook Medical Inc., Neuromedex GmbH, W.L Gore & Associates Inc. Terumo Medical Corporation.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the transjugular intrahepatic portosystemic shunt (TIPS) market analysis from 2021 to 2031 to identify the prevailing transjugular intrahepatic portosystemic shunt (TIPS) market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the transjugular intrahepatic portosystemic shunt (tips) market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global transjugular intrahepatic portosystemic shunt (tips) market trends, key players, market segments, application areas, and market growth strategies.

Transjugular Intrahepatic Portosystemic Shunt (TIPS) Market Report Highlights

Aspects Details
Market Size By 2031 USD 127.9 million
Growth Rate CAGR of 3.2%
Forecast period 2021 - 2031
Report Pages 206
By End User
  • Hospitals
  • Specialty Clinics
  • Others
By Device Type
  • Stents
  • Accessories
By Application
  • Portal hypertension
  • Budd Chiari Syndrome
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest Of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest Of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest Of LAMEA)
Key Market Players W. L. Gore & Associates, Inc. , BD, Terumo Medical Corporation, Neuromedex GmbH, Company 9, AngioDynamics Inc., Cook, Company 10, Company 8, Boston Scientific Corporation
 

Loading Table Of Content...


 
 

This section provides opinions of top level CXOs in the transjugular intrahepatic portosystemic shunt market. According to CXOs, transjugualr intrahepatic portosystemic shunt represents major usage in treatment of complications of portal hypertension. As per CXOs, the medical device industry is undertaking rapid and exceptional measures to bring more innovative products for patients and has opened new approaches in the medical device industry. For instance, in April 2022, Argon Medical Devices Inc. has launched two portal vein access sets for interventional procedures namely Scorpion portal vein. The Scorpion portal vein access addresses common challenges, when placing transjugular intrahepatic portosystemic shunt. It is designed for treatment of liver disease and to improve physical ability to navigate through liver parenchyma and reduce number of attempts necessary to establish access of portal vein. Thus, rise in number of product launches drive growth of the transjugualr intrahepatic portosystemic shunt (TIPS) market.

CXOs further added that accessories segment holds the largest share in the market, owing to rise in prevalence of diseases such as portal hypertension and Budd-Chiari Syndrome in the market. Moreover, North America is expected to offer lucrative opportunities to the market during the forecast period, owing to rise in geriatric population in the region led to increase in the number of cases of liver diseases. Thus, rise in demand for transjugular intrahepatic portosystemic shunt across the region. However, Asia-Pacific registered the fastest growth rate during the forecast period, owing to developments in healthcare infrastructure, rise in disposable incomes, and emerging domestic companies in the region.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. Growing prevalence of liver disease such as portal hypertension, Budd-Chirai Syndrome and others, increase in risk of organ failure, and development of new surgical devices by large number of key players are some of the major driving factors of the market

A. Among device type, stents segment dominated the Transjugular Intrahepatic Portosystemic Shunt (TIPS) Market in 2021

A. North America is largest regional market for Transjugular Intrahepatic Portosystemic Shunt (TIPS)

A. In 2021, the estimated industry size of Transjugular Intrahepatic Portosystemic Shunt (TIPS) was around US$ 93.4 Million

A. Boston Scientific Corporation, Becton Dickinson and Company, Angiodynamics Inc, Cook Medical Inc., are some of the top companies to hold the market share in Transjugular Intrahepatic Portosystemic Shunt (TIPS)

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS

Purchase Full Report of
Transjugular Intrahepatic Portosystemic Shunt (tips) Market

Start reading instantly.
This Report and over 53,854+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Oct 2023 - Oct 2024)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2023 - Oct 2024)
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2023 - Oct 2024)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2023 - Oct 2024)
  • Enterprise
    License/PDF

  • $9,600
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2023 - Oct 2024)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers